Inhibrx Biosciences: Pay

Inhibrx Biosciences paid its 3 named executives $5.3M in total in FY2025 (Dec). CEO Mark P. Lappe was paid $2.9M of that.

Pay$100 in the stock at the end of FY24 → $513

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Mark P. LappeChief Executive Officer and Chairman of the Board of Directors


FY2025 (Dec)
FY2023 (Dec)

2 years

David J. Matly, M.B.A.President


FY2025 (Dec)

1 year

Kelly D. Deck, C.P.A.Chief Financial Officer


FY2025 (Dec)
FY2023 (Dec)

2 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.